| Health Care Equipment & Supplies Industry | Healthcare Sector | Ms. Helen Giza CEO | B3 Exchange | - ISIN |
| Germany Country | 113,079 Employees | 21 May 2026 Last Dividend | - Last Split | - IPO Date |
Fresenius Medical Care AG is a global leader in providing dialysis and related services to individuals suffering from renal diseases. The company operates across Germany, North America, and other international locations, delivering comprehensive care for patients with end-stage renal disease (ESRD) and acute kidney failure. Fresenius Medical Care AG engages in offering dialysis treatment, along with laboratory and diagnostic services, through its network of outpatient dialysis clinics. Additionally, it provides materials, training, and patient support services, including clinical monitoring and supply delivery. The company also extends its expertise to hospitals in the United States by offering dialysis services for hospitalized ESRD patients and those with acute kidney failure. Founded in 1996, Fresenius Medical Care AG has its headquarters in Bad Homburg, Germany, and maintains a reputation for developing, manufacturing, and distributing a wide range of healthcare products aimed at improving the quality of life for patients worldwide.
Fresenius Medical Care AG offers an extensive portfolio of products and services catering to the needs of renal disease patients and healthcare providers, including:
Fresenius Medical Care AG markets its products and services directly to dialysis clinics, hospitals, and specialized treatment centers through local sales forces, independent distributors, dealers, and sales agents, ensuring comprehensive coverage and accessibility for those in need.